Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Autologous Induced Pluripotent Stem Cell-derived Dopaminergic Progenitor Cell Transplantation for Parkinson's Disease

NCT06687837 is registered in ClinicalTrials.gov with Jeffrey S. Schweitzer, MD, PhD as lead sponsor.

NCT NCT06687837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Autologous Induced Pluripotent Stem Cell-derived Dopaminergic Progenitor Cell Transplantation for Parkinson's Disease
Lead sponsor
Jeffrey S. Schweitzer, MD, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
April 29, 2025
Completion date
December 31, 2028
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease